Results 11 to 20 of about 1,309,837 (294)

Ribavirin aerosol in hospitalized adults with respiratory distress and COVID‐19: An open‐label trial

Clinical and Translational Science, 2023
There is an unmet medical need for effective treatments for hospitalized patients with coronavirus disease 2019 (COVID‐19). Ribavirin is a broad‐spectrum antiviral with demonstrated in vitro activity against multiple viruses, including severe acute ...
Garyfallia Poulakou, Maxime Barakat, Robert J. Israel, Marcelo R. Bacci, Virazole Collaborator Group for COVID‐19 Respiratory Distress   +4 more
doaj   +2 more sources

Expert consensus on the precise classification and diagnosis of acute respiratory distress syndrome [PDF]

Zhongguo Linchuang Yixue
Acute respiratory distress syndrome (ARDS) is a common critical illness in clinical practice, with a high mortality rate. Given the limited traditional treatment options for ARDS and the high heterogeneity among patients, most clinical trials have failed
Expert Group for Precise Classification and Diagnosis of Acute Respiratory Distress Syndrome
doaj   +2 more sources

Acute respiratory distress syndrome [PDF]

European Respiratory Review, 2017
Since its first description, the acute respiratory distress syndrome (ARDS) has been acknowledged to be a major clinical problem in respiratory medicine. From July 2015 to July 2016 almost 300 indexed articles were published on ARDS.
Marco Confalonieri, Francesco Salton, Francesco Fabiano   +2 more
doaj   +2 more sources

Simultaneous intratracheal administration of surfactant and budesonide in the prevention of bronchopulmonary dysplasia in the treatment of respiratory distress syndrome in premature infants [PDF]

, 2023
Background: Premature birth is an important issue in developing and developed countries. The purpose of this study is to investigate the effect of budesonide and surfactant in the treatment of respiratory distress syndrome and the prevention of ...
Norouzi, Elahe, Aminyan Daryasari, Arezoo, Maleki, Mahsa, Farhanian, Fahimeh, Kashaki, Mandana   +4 more
core   +1 more source

Developing Highly Effective Nanoparticle mRNA Therapeutic for Pediatric Acute Respiratory Distress Syndrome. [PDF]

Adv Sci (Weinh)
Sepsis‑induced pediatric acute respiratory distress syndrome suppresses FOXF1 in lung endothelial cells which causes life‐threatening lung damage. To counter this, researchers developed nanoparticles that specifically target these cells and deliver FOXF1 mRNA.
Deng Z, Gao W, Do J, Lu D, Lan YW, Damianos A, Verma G, Siraj AA, Lowry I, Peter L, Banovich NE, Sun F, He H, Kalin TV, Kalinichenko VV.   +14 more
europepmc   +2 more sources

Comparison of 25- Hydroxy Vitamin D Levels in Premature Infants with and without Respiratory Distress [PDF]

Iranian Journal of Neonatology, 2020
Background: The 25-hydroxyvitamin D3(25-OH D3)deficiency is a common problem worldwide, and it is aprevalent incidence in neonates. Different studies investigated the relationship of vitamin D deficiency with neonatal mortality and morbidity.
Azam Ghehsareh Ardastani, Elham Hashemi, Mohadeseh Beheshtinejad, Rezvan Dorostkar   +3 more
doaj   +1 more source

Surfactant function in neonates with respiratory distress syndrome [PDF]

, 1998
The function of pulmonary surfactant of a group of 14 preterm neonates (birth weight 907 +/- 60 g) who suffered from severe respiratory distress syndrome (RDS) and who had received exogenous bovine lipid extracted surfactant on the first day of life was ...
Griese, Matthias, Westerburg, Bettina, Bettina Westerburg, Matthias Griese   +3 more
core   +1 more source

Serum antioxidants as predictors of the adult respiratory distress syndrome in septic patients [PDF]

, 1993
Adult respiratory distress syndrome (ARDS) can develop as a complication of various disorders, including sepsis, but it has not been possible to identify which of the patients at risk will develop this serious disorder.
Moore, Frederick A., Parsons, Polly E., Repine, John E., Leff, Jonathan A., Jochum, Marianne, Fritz, Hans, Moore, Eugene E., McCord, Joe M., Taniguchi, Naoyuki, Day, Caroline E.   +9 more
core   +1 more source

Machine Learning–Based Discovery of a Gene Expression Signature in Pediatric Acute Respiratory Distress Syndrome

Critical Care Explorations, 2021
Objectives:. To identify differentially expressed genes and networks from the airway cells within 72 hours of intubation of children with and without pediatric acute respiratory distress syndrome.
Jocelyn R. Grunwell, MD, PhD, Milad G. Rad, MS, Susan T. Stephenson, PhD, Ahmad F. Mohammad, BS, Cydney Opolka, BS, Anne M. Fitzpatrick, PhD, Rishikesan Kamaleswaran, PhD   +6 more
doaj   +1 more source

Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol : a randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome [PDF]

, 2011
Background: The Acute Respiratory Distress Syndrome (ARDS) is a common cause of respiratory failure in critically ill patients. Experimental studies suggest that treatment with beta agonists may be helpful in ARDS.
McCabe Chris, Young Duncan, Lamb, Sarah E, Young, Duncan S., McCabe, Chris, Gao, F, Perkins, Gavin D., Gates, S, Smith, F. Gao, Lamb, S. E., Chris McCabe, Fang Gao, Young, D, Duncan Young, Gao, Fang; id_orcid, Gao Fang, Perkins, GD, Young, Duncan, Gates, Simon, Lamb, Sarah, Sarah E Lamb, Gavin D Perkins, Perkins, Gavin D, Simon Gates, Lamb Sarah E, Gates Simon, McCabe, C, Perkins Gavin D, Lamb, SE   +28 more
core   +2 more sources